Vsee Health Stock Performance
| VSEE Stock | 0.40 0.01 2.56% |
The entity has a beta of 1.86, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, VSee Health will likely underperform. At this point, VSee Health has a negative expected return of -0.2%. Please make sure to validate VSee Health's total risk alpha, expected short fall, price action indicator, as well as the relationship between the value at risk and daily balance of power , to decide if VSee Health performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days VSee Health has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's technical and fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders. ...more
1 | Why VSee Health Inc. stock is recommended by analysts - Weekly Profit Analysis Expert Curated Trade Setup Alerts - newser.com | 10/27/2025 |
2 | VSee Health Pioneers Telehealth Expansion with FedRAMP Authorization and ICU Robot Integration, Fueling 2025 Growth Surge | 11/11/2025 |
3 | VSEE Health, Inc. Delivers Robust Q3 2025 Revenue Growth Amid Telehealth Expansion Total Revenues Reach 3.98 Million, Up 19 percent Year-Over-Year | 11/17/2025 |
4 | VSeeHealth Names Dr.MiltonChenasChairman to Drive AI Infrastructure Growth | 11/20/2025 |
5 | VSee Health announces pricing of 6M private placement | 11/26/2025 |
6 | VSee and Novant Health Urgent Care Share Blueprint for Scalable, Profitable Tele-Urgent Programs | 12/04/2025 |
7 | VSee Health, Inc. Announces Postponement of Annual Meeting of Stockholders Until December 30, 2025 | 12/12/2025 |
8 | Vsee stock soars on FedRAMP news but immediate dilution risk warrants selling - MSN | 12/15/2025 |
9 | VSee Health CFO awarded retention and compensation stock grants - Stock Titan | 01/07/2026 |
10 | Acquisition by Fairfax Cydonii V. of 11029 shares of VSee Health at 1.36 subject to Rule 16b-3 | 01/16/2026 |
| Begin Period Cash Flow | 118.7 K | |
| Total Cashflows From Investing Activities | -26.1 K |
VSee Health Relative Risk vs. Return Landscape
If you would invest 62.00 in VSee Health on October 26, 2025 and sell it today you would lose (22.00) from holding VSee Health or give up 35.48% of portfolio value over 90 days. VSee Health is currently does not generate positive expected returns and assumes 11.5372% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than VSee, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
VSee Health Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for VSee Health's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as VSee Health, and traders can use it to determine the average amount a VSee Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Based on monthly moving average VSee Health is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of VSee Health by adding VSee Health to a well-diversified portfolio.
VSee Health Fundamentals Growth
VSee Stock prices reflect investors' perceptions of the future prospects and financial health of VSee Health, and VSee Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on VSee Stock performance.
| Return On Equity | -2.6 | ||||
| Return On Asset | -0.26 | ||||
| Profit Margin | (0.70) % | ||||
| Operating Margin | (0.52) % | ||||
| Current Valuation | 23.51 M | ||||
| Shares Outstanding | 33.19 M | ||||
| Price To Book | 3.63 X | ||||
| Price To Sales | 1.14 X | ||||
| Revenue | 10.42 M | ||||
| Gross Profit | 7.9 M | ||||
| EBITDA | (3.36 M) | ||||
| Net Income | (57.7 M) | ||||
| Total Debt | 9.55 M | ||||
| Book Value Per Share | (0.33) X | ||||
| Cash Flow From Operations | (5.79 M) | ||||
| Earnings Per Share | 0.46 X | ||||
| Market Capitalization | 16.5 M | ||||
| Total Asset | 19.99 M | ||||
| Retained Earnings | (67.7 M) | ||||
| Working Capital | (15.99 M) | ||||
About VSee Health Performance
By analyzing VSee Health's fundamental ratios, stakeholders can gain valuable insights into VSee Health's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if VSee Health has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if VSee Health has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (16.26) | (15.45) | |
| Return On Capital Employed | (72.77) | (69.13) | |
| Return On Assets | (3.32) | (3.49) | |
| Return On Equity | 2.8 K | 2.9 K |
Things to note about VSee Health performance evaluation
Checking the ongoing alerts about VSee Health for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for VSee Health help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| VSee Health generated a negative expected return over the last 90 days | |
| VSee Health has high historical volatility and very poor performance | |
| VSee Health has some characteristics of a very speculative penny stock | |
| VSee Health has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 10.42 M. Net Loss for the year was (57.7 M) with profit before overhead, payroll, taxes, and interest of 7.9 M. | |
| VSee Health generates negative cash flow from operations | |
| VSee Health has a frail financial position based on the latest SEC disclosures | |
| About 16.0% of the company outstanding shares are owned by insiders | |
| Latest headline from MacroaxisInsider: Acquisition by Fairfax Cydonii V. of 11029 shares of VSee Health at 1.36 subject to Rule 16b-3 |
- Analyzing VSee Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether VSee Health's stock is overvalued or undervalued compared to its peers.
- Examining VSee Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating VSee Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of VSee Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of VSee Health's stock. These opinions can provide insight into VSee Health's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for VSee Stock analysis
When running VSee Health's price analysis, check to measure VSee Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VSee Health is operating at the current time. Most of VSee Health's value examination focuses on studying past and present price action to predict the probability of VSee Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VSee Health's price. Additionally, you may evaluate how the addition of VSee Health to your portfolios can decrease your overall portfolio volatility.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |